Drug Trial Radar · NCT03181893
A Study In Adults With Moderate To Severe Dermatomyositis
Last checked: Nov 20, 2026Latest source record: Sep 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
75
Actual
Start
Jan 23, 2018
Primary completion
May 27, 2022
Study completion Nov 28, 2022
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Jun 9, 2017
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Study looking at Investigational drug and Placebo administered to adult Patients with moderate to severe Dermatomyositis
Conditions
- Dermatomyositis
Interventions
PF-06823859 lowDrug
A humanized immunoglobulin neutralizing antibody
Placebo ArmDrug
Placebo contains histidine, sucrose, PS80, ethylene diamine, and triacetic acid
PF-06823859 highDrug
A humanized immunoglobulin neutralizing antibody
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI) Activity Score at Week 12 (Stage 1, Stage 2 and Amended Stage 2)Time frame: Baseline and Week 12
- Number of Participants With Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAE) (Stage 3)Time frame: Up to Week 40
- Number of Participants With Clinically Significant Laboratory Abnormalities (Stage 3)Time frame: Up to Week 40
- Number of Participants With Vital Sign Abnormalities (Stage 3)Time frame: Baseline up to Week 40
- Number of Participants With Electrocardiogram (ECG) Abnormalities (Stage 3)Time frame: Baseline up to Week 40
Locations
41 sites in 5 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
The University of Alabama at Birmingham
Birmingham, Alabama
The University of Alabama at Birmingham
Birmingham, Alabama
Mayo Clinic Arizona Research Pharmacy
Phoenix, Arizona
Mayo Clinic
Scottsdale, Arizona
Attune Health Research Inc.
Beverly Hills, California
Freidenrich Center for Translational Research at Stanford University
Palo Alto, California
Mayo Clinic Florida
Jacksonville, Florida
University Of Miami Hospital
Miami, Florida
University of Miami Hospital Clinical Translational Research Site (Infusion site)
Miami, Florida
KU Clinical Research Center - Clinical and Translational Science Unit (CTSU)
Fairway, Kansas
The University of Kansas Medical Center
Kansas City, Kansas
Johns Hopkins Bayview Medical Center
Baltimore, Maryland
Brigham and Women's Hospital - ACC
Boston, Massachusetts
Brigham and Women's Hospital - CTC
Boston, Massachusetts
Brigham and Women's Hospital - CTH
Boston, Massachusetts
Brigham and Women's Hospital
Boston, Massachusetts
Clinical Research Unit (CRU)
Minneapolis, Minnesota
Department of Medicine Division of Rheumatic and Autoimmune Disease
Minneapolis, Minnesota
Lillehei Clinical Research Unit (LCRU)
Minneapolis, Minnesota
University of Minnesota Health Rheumatology Clinic
Minneapolis, Minnesota
University of Minnesota, Department of Dermatology
Minneapolis, Minnesota
Center for Outpatient Health
St Louis, Missouri
Washington University School of Medicine
St Louis, Missouri
New York University School of Medicine
New York, New York
NYU Langone Health Clinical Research Center
New York, New York
Mount Sinai Doctors Dermatology
New York, New York
Cleveland Clinic Foundation
Cleveland, Ohio
OHSU, Center for Health and Healing CHH2
Portland, Oregon
Oregon Clinical & Translational Research Institute
Portland, Oregon
Oregon Health & Science University
Portland, Oregon
University of Pennsylvania
Philadelphia, Pennsylvania
University of Texas Southwestern Medical Center
Dallas, Texas
University of Utah MidValley Dermatology
Murray, Utah
Center for Clinical & Translational Science
Salt Lake City, Utah
Universitaetsklinikum Tuebingen
Tübingen, Germany
University of Debrecen
Debrecen, Hajdú-Bihar, Hungary
Nova Reuma spolka partnerska
Bialystok, Poland
Centrum Medyczne Plejady
Krakow, Poland
Hospital Universitario 12 de Octubre
Madrid, Spain
Showing 40 of 41 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.